Skip to main content
. Author manuscript; available in PMC: 2013 Nov 10.
Published in final edited form as: Virology. 2012 Aug 22;433(1):183–191. doi: 10.1016/j.virol.2012.08.002

Table 1.

LHV4 genes for which predictions were made regarding functional properties and comparison with other simplexviruses

LHV-4a CeHV-2a HHV-2a BHV-2a#
Gene Predicted Functions** aa %*/aa %*/aa %*/aa
RL2 immediate early protein 569 42.7/688 43.2/702
orf7 Hypothetical protein 132
orf8 Hypothetical protein 70
UL1 glycoprotein L 156 53.6/232 54/204
UL2 uracil-DNA glycosylase 245 57.4/316 64/255
UL3 nuclear phosphoprotein 202 55.6/227 62/233 70/213
UL4 nuclear protein 206 48.2/204 46/201 62/210
UL5 helicase-primase helicase subunit 885 78.3/875 74/881
UL6 capsid portal protein 651 57.9/678 61/678
UL7 tegument protein 283 46.4/296 48/296
UL8 helicase-primase subunit 733 37.6/758 39/752 52/733
UL9 DNA replication-origin replication helicase 831 64.5/879 69/867
UL10 glycoprotein M 410 45.2/450 51/467
UL11 myristylated tegument protein 86 45.9/87 42/96
UL12 alkaline exonuclease 577 53/615 49/620
UL13 tegument serine/threonine protein kinase 504 51.7/514 54/518
UL14 tegument protein 285 52.6/214 60/219
UL15 exon1 DNA packaging terminase subunit 1 466 65.5/343 66/343
UL15 exon2 DNA packaging terminase subunit 1 609 75.4/392 79/391
UL16 tegument protein 347 47.7/362 49/449
UL17 DNA packaging tegument protein 672 55/703 56/702
UL18 capsid protein 314 72.4/317 70/318 80/316
UL19 major capsid protein 1025 70.9/1377 74/1374 84/1385
UL20 envelope protein 223 50.7/225 48/222 64.4/223
UL21 tegument protein 521 41.8/526 44/532 56/522
UL22 glycoprotein H 845 40.5/863 42/838 57/867
UL23 thymidine kinase 310 42.4/378 47/376 56/323
UL24 nuclear protein 258 51.8/260 50/281 64/265
UL25 DNA packaging tegument protein 580 59.3/577 65/585 72/579
UL26 capsid maturation protease 539 61.1/594 52/636 50/562
UL26.5 capsid morphogenesis; capsid scaffold protein 336 43.7/292 38.6/329 49/292
UL27 glycoprotein B 878 68/885 66.7/901 79/917
UL28 DNA packaging terminase subunit 2 771 60.6/784 64/785 71/664
UL29 ICP8 single-stranded binding protein 1295 65.7/1196 74/1196 80/1186
orf54 Hypothetical protein 119
UL30 DNA polymerase 1178 68/1226 65/1240 73/1211
UL31 nuclear egress laminar protein 375 66.9/304 70/305
UL32 DNA packaging protein 612 57.6/590 62/598
UL33 DNA packaging protein 159 54.7/135 59/130
UL34 nuclear egress protein 258 64.9/266 69/276
UL35 small capsid protein 105 54/114 56/112
UL36 large tegument protein 2803 51/3070 50/3122
UL37 tegument protein 1071 54.5/1271 59/1114
UL38 triplex capsid protein VP19C 501 48.8/459 59/466
orf73 Hypothetical protein 49
UL39 ribonucleotidereductase subunit 1 890 63.8/975 61/1142 75/784
UL40 Ribonucleotide reductase subunit 2 314 74.4/325 75/337 83/313
UL41 tegument host shut off protein 484 51.9/484 54/492 66/487
orf79 Hypothetical protein 94
UL42 DNA polymerase processivity factor 454 44.9/438 59/470 52/449
UL43 envelope protein 401 26.1/381 30/414 51/391
orf83 Hypothetical protein 42
UL44 glycoprotein C 429 43.3/464 40/480 56/425
UL45 Envelope protein UL45 158 42.3/174 43/172 55/166
UL46 tegument protein VP11/12 632 45.3/680 49/721
UL47 tegument protein VP13/14 676 46.9/674 51/696
UL48 transactivating tegument protein VP16 523 52.6/488 53/490
orf92 Hypothetical protein 99
UL49 Tegument protein VP22 206 38.2/275 42.1/300
UL49A Glycoprotein N 97 50/78 33.3/87
UL50 deoxyuridine triphosphatase 360 39.2/367 40/369
UL51 tegument protein 239 66/228 58/244
UL52 helicase primase subunit 1038 57/1053 56/1066
UL53 glycoprotein K 334 53/335 56/338
UL54 ICP27 502 30/510 47/512
UL55 nuclear protein 181 40.9/191 47/186 65/193
UL56 membrane protein 150 27.8/226 38.5/235
orf109 Hypothetical protein 150
RL2 ICP0 569 42.7/688 43.2/702
orf116 Hypothetical protein 600
RS1 transcription activator, ICP4 771 51.9/1185 45.1/1277
orf120 Hypothetical protein 682
orf123 Hypothetical protein 144
orf125 Hypothetical protein 86
US1 ICP22 384 40/431 43/413
US2 virion protein 325 48/276 43/291
US3 protein kinase 784 57/454 61/481
US4 glycoprotein G 808 36/606 33/699
orf130 Hypothetical protein
US6 glycoprotein D 403 60/395 63/393
US7 Virion glycoprotein I 335 32.7/399 35/372
US8 glycoprotein E 504 35/540 38/545
US8.5 membrane protein 96 48.9/102 54.5/146
US9 type 2 membrane protein; tegument-associated; localizes envelope proteins 88 32.4/91 39/89
US10 virion protein 153 41/276 34/302
US11 translational regulation 349 42.3/115 38/151
US12 inhibits antigen presentation #TAP transporter inhibitor ICP47 133 59.2/78 42.1/86
orf140 Hypothetical protein 86
orf142 Hypothetical protein 47
orf143 Hypothetical protein 369
RS1 transcription activator, ICP4 771 51.9/1185 45.1/1277
*

percentage of pair ID;

**

predicted functions derived from simplexviruses

a

accession number for LHV-4, CeHV-2, HHV-2, and BHV-2 are JQ596859, AY714813, JN561323 and AAA46053, respectively.

#

BHV-2 genome has not been fully sequenced yet.